Product Information
TURQOZ-28 TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.2930 per EA under NDC 68180089513. Its NADAC has been published 140 times since Dec 20, 2023.
FDA first approved this application on Jul 31, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180089513
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA202980FDA Approved
7/31/2023
TE Code
AB
On Market Since
11/29/2023
Price Statistics
The NADAC for TURQOZ-28 TABLET has been published 140 times since Dec 20, 2023, and over the history we have for it it has declined 23.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2930 per EA |
|---|---|
| All-time high | $0.4077 (Apr 10, 2024) |
| All-time low | $0.2841 (Jul 22, 2026) |
| 52-week high | $0.3813 |
| 52-week low | $0.2841 |
| Median price | $0.3667 |
| Average price | $0.3549 |
| Largest weekly change | +27.0% (Aug 21, 2024) |
| Weeks tracked | 140 |
| Tracking since | Dec 20, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the norgestrel and ethinyl estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TURQOZ-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TURQOZ-28 TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.2930 per EA (NDC 68180089513), effective Aug 19, 2026.
How has the price of TURQOZ-28 TABLET changed over time?
Over the history we have for it, the NADAC for TURQOZ-28 TABLET has declined 23.4%. It has been tracked across 140 weekly CMS publications since Dec 20, 2023.
What are the highest and lowest recorded NADAC prices for TURQOZ-28 TABLET?
Since Dec 20, 2023, the NADAC for TURQOZ-28 TABLET has ranged from a low of $0.2841 (Jul 22, 2026) to a high of $0.4077 (Apr 10, 2024), with a median of $0.3667 per EA.
Are there cheaper alternatives to TURQOZ-28 TABLET?
No other NADAC-published product currently shares the active ingredient and strength of TURQOZ-28 TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TURQOZ-28 TABLET?
TURQOZ-28 TABLET (NDC 68180089513) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.